Analysis of the data, stratified according to gender within each group, showed that in both MS patients and HCs, the magnitude of ETX-specific IgM and IgA responses was similar in women compared to men, while IgG response was significantly increased in men (Figure 2B). This evidence concerns the gene CD40LG and myeloid sarcoma.